Literature DB >> 12778154

Prime boost vaccines power up in people.

Harriet L Robinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12778154     DOI： 10.1038/nm0603-642

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  8 in total

1.  Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor.

Authors:  Ann Chahroudi; Rahul Chavan; Natalia Kozyr; Natalia Koyzr; Edmund K Waller; Guido Silvestri; Mark B Feinberg
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 2.  Design of vaccine adjuvants incorporating TNF superfamily ligands and TNF superfamily molecular mimics.

Authors:  Sachin Gupta; James M Termini; Saravana Kanagavelu; Geoffrey W Stone
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

3.  Interactions between human immunodeficiency virus type 1 and vaccinia virus in human lymphoid tissue ex vivo.

Authors:  Christophe Vanpouille; Angélique Biancotto; Andrea Lisco; Beda Brichacek
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

4.  A DNA vaccine prime followed by a liposome-encapsulated protein boost confers enhanced mucosal immune responses and protection.

Authors:  Kejian Yang; Barbara J Whalen; Rebecca S Tirabassi; Liisa K Selin; Tatyana S Levchenko; Vladimir P Torchilin; Edward H Kislauskis; Dennis L Guberski
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

5.  Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions.

Authors:  Elena Quaglino; Simona Rolla; Manuela Iezzi; Michela Spadaro; Piero Musiani; Carla De Giovanni; Pier Luigi Lollini; Stefania Lanzardo; Guido Forni; Remo Sanges; Stefania Crispi; Pasquale De Luca; Raffaele Calogero; Federica Cavallo
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

6.  Prime-boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu+ metastatic breast cancer in mice.

Authors:  Xiaoyan Wang; Jian-Ping Wang; Xiao-Mei Rao; Janet E Price; Heshan S Zhou; Lawrence B Lachman
Journal:  Breast Cancer Res       Date:  2005-05-23       Impact factor: 6.466

7.  Comparative ability of various plasmid-based cytokines and chemokines to adjuvant the activity of HIV plasmid DNA vaccines.

Authors:  Rong Xu; Shakuntala Megati; Vidia Roopchand; Amara Luckay; Amjed Masood; Dorys Garcia-Hand; Margherita Rosati; David B Weiner; Barbara K Felber; George N Pavlakis; Maninder K Sidhu; John H Eldridge; Michael A Egan
Journal:  Vaccine       Date:  2008-07-25       Impact factor: 4.169

8.  Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model.

Authors:  Yesim Eralp; Xiaoyan Wang; Jian-Ping Wang; Maureen F Maughan; John M Polo; Lawrence B Lachman
Journal:  Breast Cancer Res       Date:  2004-04-07       Impact factor: 6.466
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.